
Bank of America Upgrades Biotech Firm Everpure Following Market Reassessment
Bank of America analysts have reversed their previous stance and issued a bullish recommendation for newly public biotechnology company Everpure. The upgrade signals growing institutional confidence in the firm’s clinical pipeline and near-term commercial prospects.
The Story
Analyzing sources…

